Adverse Drug Reactions and Safety Profiles in Cardiovascular Drug Therapy: A Pharmacovigilance Analysis

A Pharmacovigilance Study on Psychotropic Agent-Induced Urinary Retention Using the Japanese Adverse Drug Event Report Database

Pharmacovigilance in Action: Utilizing VigiBase Data to Improve Clozapine Safety

A systematic review of efficacy and safety of newer drugs approved from 2016 to 2023 for the treatment of complicated urinary tract infections

Possible Adverse Effects (AEs) of Semaglutide (Ozempic) Administration for the Latest Investigation

Pharmacovigilance analysis of drug-induced hypobrinogenemia using the FDA Adverse Event Reporting System

Assessment of the supply chain vulnerabilities for the first tranche of the Union list of critical medicines: Technical report

Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications: A Randomized Pragmatic Trial

Gabapentinoids and Risk of Hip Fracture

Nurse Burnout and Patient Safety, Satisfaction, and Quality of Care. A Systematic Review and Meta-Analysis

Early Appropriate Antibiotic Use for CRE and MDR P. aeruginosa Infections: Epidemiology, Risk Factors, and Diagnostics

A critical pathway to reducing maternal, newborn and child mortality

As GLP-1 Use Surges, Clinicians Weigh Benefits and Risks

Dealing with adverse drug reactions in the context of polypharmacy using regression models

Systematic review and meta-analysis on effectiveness of strategies for enhancing adverse drug reaction reporting

Drug Prices Negotiated by Medicare vs US Net Prices and Prices in Other Countries

Assessing acute kidney injury risk after COVID vaccination and infection in a large cohort study

Global Risk of AKI and Tubulointerstitial Nephritis following Anticancer Drug Administration, 1967-2023: Long-Term Pharmacovigilance Analysis FR-PO038

Advances in nanomaterials for precision drug delivery: Insights into pharmacokinetics and toxicity

Signals of Possibly Persistent Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Disproportionality Analysis Using the EudraVigilance Database

Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines. A Randomized Clinical Trial

Perspective Chapter: Application of Artificial Intelligence in Pharmacovigilance Practices

A real-world study of denosumab-related hypocalcaemia based on the US food and Drug Administration Adverse Event Reporting System database

Safety of the contrast enhancement agent sulfur hexafluoride in ultrasound: Analysis of the Federal Drug Administration Adverse Event Reporting System database

Safety Profile of Biological Drugs in Clinical Practice: A Retrospective Pharmacovigilance Study

Effectiveness of an intervention to improve pharmacovigilance among selected government hospitals in a district of Sri Lanka

What are the unintended patient safety consequences of healthcare technologies? A qualitative study among patients, carers and healthcare providers

Advancing the management of maternal, fetal, and neonatal infection through harnessing digital health innovations

Using digital health technologies to optimise antimicrobial use globally

Serious adverse events reported with benzimidazole derivatives: A disproportionality analysis from the World Health Organization’s pharmacovigilance database

Drug risks associated with sarcopenia: a real-world and GWAS study

Isotretinoin and Suicide: Data Mining of the United States Food and Drug Administration Adverse Event Reporting System Database

Using multiple drug similarity networks to promote adverse drug event detection

Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase

Descriptive analysis of adverse events following immunization with oral cholera vaccine in Lebanon

Drug-related problems among pediatric intensive care units: prevalence, risk factors, and clinical pharmacists’ interventions

Reusability report: exploring the utility of variational graph encoders for predicting molecular toxicity in drug design

Anti-Cancer Drug-Induced Lyell’s Syndrome: A Series of Two Patients

The evolution of the Pharmacovigilance department in the pharmaceutical industry: results of an Italian national survey

Evaluating Sex-Biased Adverse Event-Associated Drugs to Improve Kidney Disease Drug Prioritization TH-PO116